-
Mutations in introns give rise to cystic fibrosis, breast cancer or forms of anemia.
FORBES: On The Cover/Top Stories
-
In March, NICE ruled against the use of two drugs, Lapatinib and Sutent, that prolong the life of those with certain forms of breast and stomach cancer.
WSJ: Of NICE and Men
-
He said PARP-inhibitors might also be good for treating other forms of breast cancer that behave in a similar way, which account for a fifth of all breast tumours.
BBC: Image of breast cancer